Safety and Clinical Activity of MK-3475 as Initial Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

被引：6

作者：

Balmanoukian, A. S. ^{[1
]}

Rizvi, N. A. ^{[2
]}

Garon, E. B. ^{[3
]}

Patnaik, A. ^{[4
]}

Gandhi, L. ^{[5
]}

Leighl, N. B. ^{[6
]}

Goldman, J. W. ^{[7
]}

Eder, J. P. ^{[8
]}

Johnson, E. A. ^{[9
]}

Blumenschein, G. R. ^{[10
]}

Gubens, M. A. ^{[11
]}

Papadopoulos, K. P. ^{[4
]}

Lubiniecki, G. M. ^{[12
]}

Zhang, J. ^{[13
]}

Niewood, M. ^{[12
]}

Emancipator, K. ^{[14
]}

Dolled-Filhart, M. ^{[15
]}

Hanson, M. E. ^{[16
]}

Hui, R. ^{[17
]}

机构：

[1] Angeles Clin & Res Inst, Los Angeles, CA USA

[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[4] South Texas Accelerated Res Therapeut, San Antonio, TX USA

[5] Dana Farber Canc Inst, Boston, MA 02115 USA

[6] Princess Margaret Canc Ctr UHN, Toronto, ON, Canada

[7] Univ Calif Los Angeles, Santa Monica, CA USA

[8] Yale Univ, New Haven, CT USA

[9] Mayo Clin Florida, Jacksonville, FL USA

[10] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[11] Univ Calif San Francisco, San Francisco, CA 94143 USA

[12] Merck & Co Inc, Whitehouse Stn, NJ USA

[13] Merck & Co Inc, Gwynedd, PA USA

[14] Merck Res Labs, Rahway, NJ USA

[15] Merck & Co Inc, Rahway, NJ 07065 USA

[16] Merck & Co Inc, Rahway, NJ 07065 USA

[17] Westmead Hosp, Sydney, NSW, Australia

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷

关键词：

D O I：

10.1016/j.ijrobp.2014.08.023

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S1 / S2

页数：2

共 50 条

[41] Neoadjuvant Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
Nakagawa, Taku
Minamiya, Yoshihiro
Saito, Hajime
Imai, Kazuhiro
Konno, Hayato
Kudo, Satoshi
Saito, Yoshitaro
Kurihara, Nobuyasu
Watanabe, Shinnosuke
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S685 - S686
[42] Surgical operability of patients with locally advanced non-small cell lung cancer (NSCLC)
Lardinois, Didier
THERAPEUTISCHE UMSCHAU, 2012, 69 (07) : 411 - 419
[43] Efficacy and Safety of Sintilimab with Anlotinib as First-Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
Han, B.
Chu, T.
Zhong, R.
Zhong, H.
Zhang, B.
Zhang, W.
Shi, C.
Qian, J.
Han, Y.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S129 - S129
[44] IMPROVING TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Reck, M.
ANTICANCER RESEARCH, 2008, 28 (6B) : 4038 - 4038
[45] Cetuximab in advanced non-small cell lung cancer (NSCLC): the showdown?
Sgambato, Assunta
Casaluce, Francesca
Maione, Paolo
Rossi, Antonio
Ciardiello, Fortunato
Gridelli, Cesare
JOURNAL OF THORACIC DISEASE, 2014, 6 (06) : 578 - 580
[46] ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) TREATMENT
Goncalves, Ivone M.
Monteiro, Regina
Neves, Sofia
Conde, Sara
Campainha, Sergio
Parente, Barbara
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1298 - S1298
[47] Gemcitabine and cisplatin for advanced non-small cell lung cancer (NSCLC)
Casal, J
Grande, C
Caeiro, M
EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1083 - 1083
[48] CRIZOTINIB THERAPY FOR PATIENTS WITH ADVANCED ROS1-REARRANGED NON-SMALL CELL LUNG CANCER (NSCLC)
Ou, Sai-Hong I.
Kim, Dong-Wan
Camidge, D. Ross
Riely, Gregory
Salgia, Ravi
Shapiro, Geoffrey
Solomon, Ben
Engelman, Jeffrey A.
Kwak, Eunice L.
Clark, Jeffrey W.
Tye, Lesley
Wilner, Keith
Usari, Tiziana
Varella-Garcia, Marileila
Bergethon, Kristin
Iafrate, A. J.
Shaw, Alice T.
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S295 - S295
[49] Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study
de Castro, J.
Tagliaferri, P.
de Lima, V. C. C.
Ng, S.
Thomas, M.
Arunachalam, A.
Cao, X.
Kothari, S.
Burke, T.
Myeong, H.
Grattan, A.
Lee, D. H.
EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (06)
[50] Third-line therapy and beyond for patients with advanced/metastatic non-small cell lung cancer (NSCLC).
Corral Jaime, Jesus
Gonzalez de la Pena, Miriam
Alonso, Miriam
Sanchez Gastaldo, Amparo
Dolores Mediano, Maria
Amerigo, Marta
Enrique Robles, Carlos
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)

← 1 2 3 4 5 →